Влияние гена моноаминооксидазы типа Б на развитие леводопа-индуцированных дискинезий при болезни Паркинсона
https://doi.org/10.24411/2588-0527-2019-10041
Abstract
About the Authors
Г. АхмадееваRussian Federation
И. Хидиятова
Russian Federation
И. Гилязова
Russian Federation
Г. Таюпова
Russian Federation
А. Байтмеров
Russian Federation
Р. Магжанов
Russian Federation
References
1. Balciuniene J, Emilsson L, Oreland L, et al. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum. Genet.2002;110:1-7. DOI: 10.1007/s00439-001-0652-8
2. Sun YX, Wang XH, Xu AH, Zhao JH. Functional polymorphisms of the MAO gene with Parkinson disease susceptibility: a meta-analysis. J. Neurol. Sci. 2014;345(Pt1-2):97-105. DOI: 10.1016/j.jns.2014.07.016
3. Liu Y, Wang Z, Zhang B. The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis. Ann Saudi Med. 2014;34(1): 12-17. DOI: 10.5144/0256-4947.2014.12
4. Ахмадеева Г.Н. Роль генов системы метаболизма моноаминов в развитии болезни Паркинсона и её нейропсихологических проявлений [диссертация]. Науч. центр неврологии РАМН. – Москва; 2017. [Ahmadeeva G.N. Rol’ genov sistemy metabolizma monoaminov v razvitii bolezni Parkinsona i eyo nejropsihologicheskih proyavlenij [dissertaciya]. Nauch. centr nevrologii RAMN [dissertation] Moscow; 2017. (In Russ).] Доступно по: https://docplayer.ru/60418054-Ahmadeeva-gulnara-nailevna-rol-genov-sistemy-metabolizma-monoaminov-v-razvitii-bolezni-parkinsona-i-eyoneyropsihologicheskih-proyavleniy.html. Ссылка активна на 12.12.2019.
5. Akhmadeeva G, Khidiyatova I, Gilyazova I, et al. The role of genetic factors in levodopa-induced dyskinesias development in russian patients with parkinson’s disease: a pilot study. Proceedings of the XXIV World Congress of Neurology; 2019 Oct 27-31; Dubai, United Arab Emirates (UAE).
Review
For citations:
, , , , , . Pharmacogenetics and Pharmacogenomics. 2019;(2):4-5. (In Russ.) https://doi.org/10.24411/2588-0527-2019-10041